Researchers determined the effect of prenatal and early postnatal lead exposure on risk for depression and anxiety in adulthood.

Lumateperone is approved as an adjunctive treatment for MDD, expanding its indications beyond schizophrenia and bipolar ...

People with major depressive disorder or schizophrenia have been found to have lower levels of the synaptic protein "SNAP-25" ...

Caplyta, the crown jewel of Johnson & Johnson's $14.6 billion buyout of Intra-Cellular Therapies, won the FDA’s blessing to ...

The FDA approved lumateperone (Caplyta) as an adjunctive therapy with antidepressants for the treatment of major depressive ...

The expanded indication for the oral atypical antipsychotic now includes adjunctive use with antidepressants in adults with major depressive disorder.

Mental disorders that cause physical symptoms are not included in a major health trends study, despite them impacting as many as 1 in 21 adults, researchers have found. Somatoform disorders could be ...

Mental disorders that cause physical symptoms are not included in a major health trends study, despite them impacting as many ...

Background Major depressive disorder (MDD) is a severe mental health condition that profoundly affects both psychological and physical well-being. Growing evidence indicates that targeting the ...

Snider's supercharged relationship with her art form and open-book stance on depression and anxiety shine through in her new ...

Sri Lankan combatants experienced prolonged exposure to combat, surpassing the durations faced by veterans of World War II, Vietnam, Korea, and the Gulf War. As a result, a significant number of these ...

A young queer woman recounts how the daily experience of exclusion and isolation became a burden on her mental health.